KR20090096756A - 제2형 당뇨병에서 혈청 프로인슐린 수치의 감소 방법 - Google Patents
제2형 당뇨병에서 혈청 프로인슐린 수치의 감소 방법 Download PDFInfo
- Publication number
- KR20090096756A KR20090096756A KR1020097017808A KR20097017808A KR20090096756A KR 20090096756 A KR20090096756 A KR 20090096756A KR 1020097017808 A KR1020097017808 A KR 1020097017808A KR 20097017808 A KR20097017808 A KR 20097017808A KR 20090096756 A KR20090096756 A KR 20090096756A
- Authority
- KR
- South Korea
- Prior art keywords
- insulin
- formulation
- preparation
- serum
- levels
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (20)
- 제2형 당뇨병의 초기 단계에 있는 개인에 있어서 아테롬성 동맥경화증(atherosclerosis)의 위험 인자를 감소시키기 위한 인슐린 제제로서, 상기 개인은 증가된 혈청 프로인슐린 수치를 가지며, 상기 인슐린 제제는 식이 방식으로, 생리적 식사 관련 제1상 인슐린 반응을 모방하는 투여량으로 상기 개인에게 투여되는 것인 인슐린 제제.
- 제1항에 있어서, 인슐린의 투여량은 혈중 포도당 수치를 제어하고 프로인슐린의 혈청 수치를 감소시키기에 충분한 것인 인슐린 제제.
- 제1항에 있어서, 인슐린 제제는 폐 투여되는 것인 인슐린 제제.
- 제3항에 있어서, 인슐린 제제는 건조 분말 제제를 포함하는 것인 인슐린 제제.
- 제4항에 있어서, 건조 분말 제제는 디케토피페라진을 포함하는 것인 인슐린 제제.
- 제1항에 있어서, 인슐린 제제는 생리적 식사 관련 제1상 인슐린 반응을 모방 하는 방식으로, 그리고 혈중 포도당 수치를 조절하고 프로인슐린의 혈청 수치를 감소시키기에 충분한 투여량으로 투여되는 것인 인슐린 제제.
- 제1항에 있어서, 인슐린 제제는 식사 개시 후 약 10분 이내에 투여되는 것인 인슐린 제제.
- 제5항에 있어서, 디케토피페라진은 푸마릴 디케토피페라진인 것인 인슐린 제제.
- 제1항에 있어서, 인슐린 제제는 인슐린을 혼입한 생분해성 폴리머 또는 계면활성제 미소입자로 폐 전달에 의해 투여되는 것인 인슐린 제제.
- 제1항에 있어서, 인슐린은 이량체 또는 단량체인 것인 인슐린 제제.
- 제2항에 있어서, 인슐린의 투여량은 약 15 IU 내지 90 IU인 것인 인슐린 제제.
- 제11항에 있어서, 인슐린의 투여량은 약 24 IU 내지 48 IU인 것인 인슐린 제제.
- 제1항에 있어서, 혈청 인슐린 수치는 인슐린 제제의 투여 후 약 18분 이내에 최고치에 도달하는 것인 인슐린 제제.
- 제1항에 있어서, 혈청 인슐린 수치는 인슐린 제제의 투여 후 약 2시간 이내에 베이스라인으로 복귀하는 것인 인슐린 제제.
- 제1항에 있어서, 인슐린 제제는 식사 개시 후 약 1시간 이내에 투여되는 것인 인슐린 제제.
- 제6항에 있어서, 췌장 스트레스가 완화되는 것인 인슐린 제제.
- 제1항에 있어서, 인슐린 제제는 생리적 식사 관련 제1상 인슐린 반응을 모방하는 방식으로, 그리고 글루코네오제네시스(gluconeogenesis)를 차단하기에 충분한 투여량으로 투여되는 것인 인슐린 제제.
- 제1항에 있어서, 위험 인자는 증가된 혈청 프로인슐린이고, 혈청 프로인슐린이 감소하게 되는 것인 인슐린 제제.
- 제1항에 있어서, 위험 인자는 저밀도 지질단백질(LDL) 입자 크기이고, LDL 입자 크기가 증가하게 되는 것인 인슐린 제제.
- 제1항에 있어서, 위험 인자는 플라스미노겐 활성화제 저해제 타입-1(PAI-1)이고, PAI-1 발현이 감소하게 되는 것인 인슐린 제제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53594504P | 2004-01-12 | 2004-01-12 | |
US60/535,945 | 2004-01-12 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067013980A Division KR20060110353A (ko) | 2004-01-12 | 2005-01-10 | 제2형 당뇨병 환자에서 혈청 프로인슐린 농도의 감소 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090096756A true KR20090096756A (ko) | 2009-09-14 |
KR100985126B1 KR100985126B1 (ko) | 2010-10-05 |
Family
ID=34794375
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067013980A KR20060110353A (ko) | 2004-01-12 | 2005-01-10 | 제2형 당뇨병 환자에서 혈청 프로인슐린 농도의 감소 방법 |
KR1020097017808A KR100985126B1 (ko) | 2004-01-12 | 2005-01-10 | 제2형 당뇨병에서 혈청 프로인슐린 수치의 감소 방법 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020067013980A KR20060110353A (ko) | 2004-01-12 | 2005-01-10 | 제2형 당뇨병 환자에서 혈청 프로인슐린 농도의 감소 방법 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050153874A1 (ko) |
EP (1) | EP1708738B1 (ko) |
JP (1) | JP2007517892A (ko) |
KR (2) | KR20060110353A (ko) |
CN (1) | CN101027082A (ko) |
AU (2) | AU2005204378B2 (ko) |
BR (1) | BRPI0506791A (ko) |
CA (1) | CA2552707C (ko) |
ES (1) | ES2584867T3 (ko) |
IL (1) | IL176699A (ko) |
NZ (1) | NZ548980A (ko) |
WO (1) | WO2005067964A1 (ko) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
ES2526707T3 (es) * | 1999-06-29 | 2015-01-14 | Mannkind Corporation | Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos |
SI1494732T1 (sl) | 2002-03-20 | 2008-08-31 | Mannking Corp | Inhalacijski aparat |
US7338171B2 (en) * | 2003-10-27 | 2008-03-04 | Jen-Chuen Hsieh | Method and apparatus for visual drive control |
US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
US20080090753A1 (en) * | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
PT1740154E (pt) * | 2004-03-12 | 2009-09-11 | Biodel Inc | Composições de insulina com absorção melhorada |
JP5078014B2 (ja) | 2004-08-20 | 2012-11-21 | マンカインド コーポレイション | ジケトピペラジン合成の触媒反応 |
HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
CA2592776A1 (en) * | 2005-01-10 | 2006-08-17 | Mannkind Corporation | Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
ES2439455T3 (es) * | 2005-08-01 | 2014-01-23 | Mannkind Corporation | Procedimiento de preservar la función de las células productoras de insulina |
EP1928423B1 (en) * | 2005-09-14 | 2015-12-09 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
WO2007041481A1 (en) * | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
US8084420B2 (en) * | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US7713929B2 (en) | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
JP2009533471A (ja) * | 2006-04-12 | 2009-09-17 | バイオデル, インコーポレイテッド | 即効型および長時間作用型組合せインスリン製剤 |
WO2008124522A2 (en) * | 2007-04-04 | 2008-10-16 | Biodel, Inc. | Amylin formulations |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
CN101951957A (zh) * | 2008-01-04 | 2011-01-19 | 百达尔公司 | 胰岛素释放作为组织的葡萄糖水平的函数的胰岛素制剂 |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
KR101558026B1 (ko) | 2008-06-13 | 2015-10-06 | 맨카인드 코포레이션 | 건조 분말 흡입기 및 약물 투여 시스템 |
CA2728523C (en) | 2008-06-20 | 2020-03-10 | Mannkind Corporation | An interactive apparatus and method for real-time profiling of inhalation efforts |
US11110151B2 (en) * | 2008-08-11 | 2021-09-07 | Mannkind Corporation | Composition and method for reducing hypoglycemia events in diabetes treatment |
TWI614024B (zh) * | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
AU2010203573A1 (en) * | 2009-01-08 | 2011-06-30 | Mannkind Corporation | Method for treating hyperglycemia with GLP-1 |
US9060927B2 (en) * | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
EP2440184B1 (en) | 2009-06-12 | 2023-04-05 | MannKind Corporation | Diketopiperazine microparticles with defined specific surface areas |
CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
CA2801936C (en) | 2010-06-21 | 2021-06-01 | Mannkind Corporation | Dry powder drug delivery system and methods |
KR101940832B1 (ko) | 2011-04-01 | 2019-01-21 | 맨카인드 코포레이션 | 의약 카트리지용 블리스터 패키지 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
EP2776053A1 (en) | 2011-10-24 | 2014-09-17 | MannKind Corporation | Methods and compositions for treating pain |
CA2878457C (en) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Dry powder drug delivery systems and methods |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
WO2014144895A1 (en) | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
CN110187123B (zh) * | 2019-05-06 | 2022-07-22 | 天津医科大学总医院 | 一种糖尿病早期诊断生物标志物及其应用 |
CN111235036B (zh) * | 2020-01-15 | 2022-03-18 | 西北大学 | 一种冠突散囊菌及从其中分离纯化二酮哌嗪二聚体的方法 |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2224175B1 (ko) * | 1973-04-04 | 1978-04-14 | Isf Spa | |
GB1479283A (en) * | 1973-07-23 | 1977-07-13 | Bespak Industries Ltd | Inhaler for powdered medicament |
US4153689A (en) * | 1975-06-13 | 1979-05-08 | Takeda Chemical Industries, Ltd. | Stable insulin preparation for nasal administration |
US4211769A (en) * | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
US4272398A (en) * | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
JPS6034925B2 (ja) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
US5260306A (en) * | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
US4659696A (en) * | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
US4946828A (en) * | 1985-03-12 | 1990-08-07 | Novo Nordisk A/S | Novel insulin peptides |
US5785989A (en) * | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
US5042975A (en) * | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
USRE35862E (en) * | 1986-08-18 | 1998-07-28 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
DE3779221D1 (de) * | 1986-08-19 | 1992-06-25 | Genentech Inc | Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen. |
US4861627A (en) * | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
US5514646A (en) * | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
US5188837A (en) * | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
US5693338A (en) * | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US6331318B1 (en) * | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
IL99699A (en) * | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
AU1442592A (en) * | 1991-02-20 | 1992-09-15 | Nova Pharmaceutical Corporation | Controlled release microparticulate delivery system for proteins |
US5492112A (en) * | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
CA2070061C (en) * | 1991-06-07 | 2004-02-10 | Shigeyuki Takama | Physiologically active polypeptide-containing pharmaceutical composition |
JP3230056B2 (ja) * | 1991-07-02 | 2001-11-19 | インヘイル・インコーポレーテッド | 薬剤のエーロゾル化服用量を形成する装置 |
US6063910A (en) * | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
JP3121080B2 (ja) * | 1991-12-19 | 2000-12-25 | アール・ピー・シーラー コーポレイション | カプセル封入用溶液 |
CA2127877A1 (en) * | 1992-01-21 | 1993-07-22 | Robert M. Platz | Improved process for preparing micronized polypeptide drugs |
US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
SK279327B6 (sk) * | 1992-10-19 | 1998-10-07 | Dura Pharmaceuticals | Zariadenie na vytváranie aerosolu z práškového lie |
US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US5364838A (en) * | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
IS1796B (is) * | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
US5747445A (en) * | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5562909A (en) * | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
CA2176712C (en) * | 1993-11-16 | 2000-05-23 | Mantripragada Sankaram | Synthetic membrane vesicles with controlled release of encapsulated biologically active substances |
US5484606A (en) * | 1994-01-24 | 1996-01-16 | The Procter & Gamble Company | Process for reducing the precipitation of difficulty soluble pharmaceutical actives |
AU689217B2 (en) * | 1994-03-07 | 1998-03-26 | Novartis Ag | Methods and compositions for pulmonary delivery of insulin |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
US6395744B1 (en) * | 1994-04-22 | 2002-05-28 | Queen's University At Kingston | Method and compositions for the treatment or amelioration of female sexual dysfunction |
US5547929A (en) * | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
CN1170409A (zh) * | 1994-12-01 | 1998-01-14 | 富山化学工业株式会社 | 新的2,3-二氧代哌嗪衍生物及其盐 |
US5901703A (en) * | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
US5653961A (en) * | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
US6428771B1 (en) | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
US5849322A (en) * | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
AU7678196A (en) * | 1995-11-13 | 1997-06-05 | Minimed, Inc. | Methods and compositions for the delivery of monomeric proteins |
DE19545257A1 (de) * | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
US6503480B1 (en) * | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
USRE37053E1 (en) * | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US6254854B1 (en) * | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
EP1029536B1 (en) * | 1997-10-01 | 2007-11-28 | Novadel Pharma Inc. | Buccal non-polar spray |
US6552024B1 (en) * | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
ES2261195T3 (es) | 1999-04-05 | 2006-11-16 | Mannkind Corporation | Metodo de formacion de particulas finas. |
US7169889B1 (en) * | 1999-06-19 | 2007-01-30 | Biocon Limited | Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
ES2526707T3 (es) * | 1999-06-29 | 2015-01-14 | Mannkind Corporation | Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos |
US6294317B1 (en) * | 1999-07-14 | 2001-09-25 | Xerox Corporation | Patterned photoresist structures having features with high aspect ratios and method of forming such structures |
US7464706B2 (en) * | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
PT1666028E (pt) * | 1999-10-29 | 2010-06-15 | Novartis Ag | Composições de pós anidros com melhor dispersividade |
US6432383B1 (en) * | 2000-03-30 | 2002-08-13 | Generex Pharmaceuticals Incorporated | Method for administering insulin |
CN1141974C (zh) * | 2000-06-07 | 2004-03-17 | 张昊 | 结肠定位释放的口服生物制剂 |
US20030096403A1 (en) * | 2000-10-02 | 2003-05-22 | Hyo-Jeong Hong | Humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
US20020138369A1 (en) | 2001-03-22 | 2002-09-26 | Calaway Douglas D. | Electronic storage medium and purchasing system and method |
WO2003035030A1 (en) * | 2001-10-24 | 2003-05-01 | Pari Gmbh | Kit for the preparation of a pharmaceutical composition |
US20030194420A1 (en) * | 2002-04-11 | 2003-10-16 | Richard Holl | Process for loading a drug delivery device |
DE10235168A1 (de) * | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
NZ540318A (en) * | 2002-10-31 | 2007-09-28 | Umd Inc | Therapeutic compositions for drug delivery to and through covering epithelia |
EP1605916A4 (en) * | 2003-02-12 | 2012-02-22 | R & P Korea Co Ltd | SOLUBENT SOLVENT SYSTEM WITH SOLUBLE PEEL WITH IMPROVED ELUTION RATE |
PT1740154E (pt) * | 2004-03-12 | 2009-09-11 | Biodel Inc | Composições de insulina com absorção melhorada |
WO2007041481A1 (en) * | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
-
2005
- 2005-01-10 CN CNA200580002306XA patent/CN101027082A/zh active Pending
- 2005-01-10 AU AU2005204378A patent/AU2005204378B2/en not_active Ceased
- 2005-01-10 JP JP2006549451A patent/JP2007517892A/ja active Pending
- 2005-01-10 US US11/032,278 patent/US20050153874A1/en not_active Abandoned
- 2005-01-10 BR BRPI0506791-0A patent/BRPI0506791A/pt not_active Application Discontinuation
- 2005-01-10 EP EP05711314.4A patent/EP1708738B1/en not_active Not-in-force
- 2005-01-10 KR KR1020067013980A patent/KR20060110353A/ko not_active Application Discontinuation
- 2005-01-10 WO PCT/US2005/000596 patent/WO2005067964A1/en active Application Filing
- 2005-01-10 NZ NZ548980A patent/NZ548980A/en not_active IP Right Cessation
- 2005-01-10 CA CA2552707A patent/CA2552707C/en not_active Expired - Fee Related
- 2005-01-10 ES ES05711314.4T patent/ES2584867T3/es active Active
- 2005-01-10 KR KR1020097017808A patent/KR100985126B1/ko active IP Right Grant
-
2006
- 2006-07-04 IL IL176699A patent/IL176699A/en not_active IP Right Cessation
-
2009
- 2009-03-06 AU AU2009200894A patent/AU2009200894B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
NZ548980A (en) | 2009-10-30 |
EP1708738B1 (en) | 2016-05-04 |
AU2005204378B2 (en) | 2009-01-22 |
AU2009200894A1 (en) | 2009-03-26 |
IL176699A (en) | 2011-11-30 |
AU2009200894B2 (en) | 2010-11-18 |
KR20060110353A (ko) | 2006-10-24 |
JP2007517892A (ja) | 2007-07-05 |
WO2005067964A1 (en) | 2005-07-28 |
AU2005204378A1 (en) | 2005-07-28 |
ES2584867T3 (es) | 2016-09-29 |
CA2552707C (en) | 2018-03-27 |
CN101027082A (zh) | 2007-08-29 |
KR100985126B1 (ko) | 2010-10-05 |
BRPI0506791A (pt) | 2007-05-22 |
IL176699A0 (en) | 2006-10-31 |
US20050153874A1 (en) | 2005-07-14 |
EP1708738A1 (en) | 2006-10-11 |
CA2552707A1 (en) | 2005-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100985126B1 (ko) | 제2형 당뇨병에서 혈청 프로인슐린 수치의 감소 방법 | |
US9801925B2 (en) | Potentiation of glucose elimination | |
US8940691B2 (en) | Method for treating metabolic disorders including type 1 and type 2 diabetes mellitus | |
AU2006275424B2 (en) | Method of preserving the function of insulin-producing cells | |
US20070027063A1 (en) | Method of preserving the function of insulin-producing cells | |
Home | Future directions in insulin therapy | |
Bloomgarden | Insulin treatment and type 1 diabetes topics | |
MXPA06007966A (en) | A method of reducing serum proinsulin levels in type 2 diabetics | |
Hosoda et al. | Articles in PresS. Am J Physiol Endocrinol Metab (January 24, 2012). doi: 10.1152/ajpendo. 00198.2011 | |
CN112010971A (zh) | 抗vegf抗体在制备预防和/或治疗脂肪肝的药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130911 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150909 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160912 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170914 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180907 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190917 Year of fee payment: 10 |